Access the full text.
Sign up today, get DeepDyve free for 14 days.
C McGuinn, JB Bussel (2016)
Lanzkowsky's Manual of Pediatric Hematology and Oncology
M. Kuwana, Y. Okazaki, J. Kaburaki, Y. Ikeda (2003)
Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia.The American journal of medicine, 114 4
P. Imbach, T. Kühne (1998)
Immune Thrombocytopenic Purpura ITPVox Sanguinis, 74
A. Rashidi, M. Blinder (2016)
Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature reviewJournal of Clinical Pharmacy and Therapeutics, 41
F. Zaja, W. Barcellini, S. Cantoni, M. Carpenedo, G. Caparrotti, V. Carrai, N. Renzo, C. Santoro, M. Nicola, D. Veneri, F. Simonetti, A. Liberati, V. Ferla, F. Paoloni, E. Crea, S. Volpetti, Enrica Tuniz, R. Fanin (2016)
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA studyAmerican Journal of Hematology, 91
A. Cuker, C. Neunert (2016)
How I treat refractory immune thrombocytopenia.Blood, 128 12
The first‐line treatment for pediatric immune thrombocytopenia (ITP) consists of observation, i.v. immunoglobulin (IVIG), or corticosteroids. Although these procedures resolve the condition in most affected children, some are refractory to treatment or relapse. Recent second‐line treatments, such as cyclosporin, rituximab or thrombopoietin receptor (TPO‐R) agonist are promising, but some patients do not respond well to them. Splenectomy remains the only salvage intervention that may induce a curative effect in nearly two‐thirds of such patients. We report a case of refractory ITP. The patient did not respond to first‐ and second‐line treatment. Concomitant use of eltrombopag and IVIG resulted in transient increase of platelet count and allowed a safer execution of splenectomy that resulted in remission of ITP. This is the first successful treatment of pediatric refractory ITP using TPO‐R agonist and IVIG.A 4‐year‐old girl saw the family physician with ecchymoses on the extremities and nasal bleeding. On laboratory analysis, platelets were 3 × 109/L, and platelet‐associated IgG concentration was 140 ng/107 cells. She was admitted to a local hospital and was diagnosed with primary ITP. IVIG with oral prednisolone therapy increased the platelet count temporarily to 50 × 109/L, but it decreased to 1 × 109/L within 1 week
Pediatrics International – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.